- Personalization Meets Precision
Engineering the Digital Twin of Human Blood
- No Shortages
- No Delays
- No Errors
- Services
Solutions we provide for the healthcare industry.
We engineer the most precise, trusted, and secure digital twin for human blood management. Our mission is to deliver real-time blood intelligence through AI-powered hemodynamic twins—enabling personalized and compliant clinical decisions.
Personalization Through Biologic Simulation
ReVessel brings a new level of precision to personalized health by simulating the dynamic behavior of
Digital Twin Engine for Real-Time Blood Intelligence
Precision Modeling, Backed By Trust
ReVessel delivers not only precision, but peace of mind. Every simulation, data stream, and algorithm within
Real Time Intelligence Support for Decision Making
ReVessel brings decision intelligence to the edge—delivering simulation-powered insights in sub-200 milliseconds directly where care is
Smarter Systems Reduced Donor Dependency
ReVessel rethinks the blood ecosystem by shifting away from reactive donor-dependent models. Our simulations allow for
Seamless Integration with Existing Infrastructure
ReVessel is designed to integrate, not replace. Our system overlays existing hospital, lab, and data infrastructure
- About us
About ReVessel
Our technology is as unique as the blood that it mirrors.
Revessel is a Florida-based precision health startup developing the first cyber-physical hemo-twin platform—an AI-powered digital twin for human blood behavior simulation and management. Using clinical, multiomics, and pharmacokinetics data, ReVessel enables real-time, ethically governed decision support across high acuity environments including trauma, transplant, sepsis, dialysis, and ICU care.
Built on a foundation of biologically precise simulation, ReVessel’s architecture is designed to scale across preventative analytics, chronic disease management and longevity science — reimagining the future of blood management.
- FAQs
Frequently
Asked Questions
What is ReVessel’s core technology?
ReVessel is developing the world’s first digital twin of human blood—an AI-powered simulation that replicates each individual’s hematologic and hemodynamic behavior with real-time responsiveness and encrypted data architecture.
Is ReVessel commercially available?
ReVessel is currently in early-stage development and not yet commercially available. We are in ongoing discussions with clinical advisors, research institutions, and ecosystem partners to co-develop and validate the platform. As we advance our technology roadmap, we are actively seeking strategic investors and collaborators who share our vision for building the infrastructure behind personalized blood management.
How does ReVessel integrate with existing hospital systems?
ReVessel is designed for interoperability. We support EMR, FHIR, OMOP, and other standard formats, enabling integration via secure APIs without requiring infrastructure overhaul. Edge deployment allows simulation and intelligence to be delivered directly at the point of care.
- blogs